COVID-19 "second wave" and vaccines: the dermatologists' perspective.
作者信息
Burlando Martina, Russo Roberto, Cozzani Emanuele, Parodi Aurora
机构信息
Di.S.Sal. Section of Dermatology, University of Genoa, Genoa, Italy.
IRCCS San Martino Polyclinic Hospital, Genoa, Italy.
出版信息
Int J Dermatol. 2021 Jul;60(7):889-890. doi: 10.1111/ijd.15547. Epub 2021 Mar 25.
Abstract
摘要
相似文献
1
COVID-19 "second wave" and vaccines: the dermatologists' perspective.
Int J Dermatol. 2021 Jul;60(7):889-890. doi: 10.1111/ijd.15547. Epub 2021 Mar 25.
2
COVID-19 vaccination challenge: history lessons from a dermatologist's perspective.
Int J Dermatol. 2021 May;60(5):620-621. doi: 10.1111/ijd.15449. Epub 2021 Mar 4.
3
Dermatologists as recipients of COVID-19 stigma.
Clin Exp Dermatol. 2021 Jun;46(4):762-763. doi: 10.1111/ced.14619. Epub 2021 Mar 17.
4
The impact of COVD-19 on North American dermatology practices.
J Cosmet Dermatol. 2021 Nov;20(11):3378-3381. doi: 10.1111/jocd.14458. Epub 2021 Sep 18.
5
Experiences of resident dermatologists during the COVID-19 pandemic: A cross-sectional survey.
Dermatol Ther. 2021 Jan;34(1):e14574. doi: 10.1111/dth.14574. Epub 2020 Nov 30.
6
Beyond traditional meetings and webinars: identifying the educational preferences of practicing dermatologists.
Dermatol Online J. 2022 Mar 15;28(2). doi: 10.5070/D328257405.
7
Impacts of COVID-19 on Dermatologic Practice, Disease Presentation, and Immunomodulator Prescriptions.
J Cutan Med Surg. 2021 Jan-Feb;25(1):106-108. doi: 10.1177/1203475420960437. Epub 2020 Sep 16.
8
COVID-19 pandemic and the skin: what should dermatologists know?
Clin Dermatol. 2020 Nov-Dec;38(6):785-787. doi: 10.1016/j.clindermatol.2020.03.012. Epub 2020 Mar 24.
9
How well prepared are dermatologists redeployed to COVID-19 wards?
Int J Dermatol. 2020 Jul;59(7):e247-e248. doi: 10.1111/ijd.14978. Epub 2020 May 25.
10
COVID-19: An overview for dermatologists.
Int J Dermatol. 2020 Dec;59(12):1437-1449. doi: 10.1111/ijd.15257. Epub 2020 Oct 27.
引用本文的文献
1
Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases.
J Taibah Univ Med Sci. 2023 Sep 5;18(6):1646-1661. doi: 10.1016/j.jtumed.2023.08.004. eCollection 2023 Dec.
2
Dermatological Manifestations in COVID-19: A Case Study of SARS-CoV-2 Infection in a Genetic Thrombophilic Patient with Mthfr Mutation.
Pathogens. 2023 Mar 10;12(3):438. doi: 10.3390/pathogens12030438.
3
Evidence-Based Guidelines for SARS-COV-2 Vaccination of Patients of Skin Allergic Diseases and Patients on Immuno-Therapeutics.
Indian J Dermatol. 2022 May-Jun;67(3):314. doi: 10.4103/ijd.ijd_440_21.
4
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Epub 2022 Jun 21.
5
Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset.
Front Immunol. 2022 Feb 18;13:834316. doi: 10.3389/fimmu.2022.834316. eCollection 2022.
6
SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.
Int J Dermatol. 2022 Oct;61(10):1187-1204. doi: 10.1111/ijd.16063. Epub 2022 Feb 9.
7
Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review.
J Cosmet Dermatol. 2022 Jan;21(1):4-12. doi: 10.1111/jocd.14613. Epub 2021 Nov 17.
8
Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review.
Viruses. 2021 Sep 24;13(10):1916. doi: 10.3390/v13101916.
9
SARS-CoV-2 Vaccines and the Skin.
Actas Dermosifiliogr. 2021 Oct;112(9):828-836. doi: 10.1016/j.adengl.2021.07.028. Epub 2021 Aug 28.
10
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
Br J Dermatol. 2022 Jan;186(1):142-152. doi: 10.1111/bjd.20639. Epub 2021 Sep 21.
本文引用的文献
1
Chilblain-like lesions and COVID-19: second wave, second outbreak.
J Eur Acad Dermatol Venereol. 2021 May;35(5):e316-e318. doi: 10.1111/jdv.17145. Epub 2021 Mar 2.
2
Fixed drug eruptions, bullous drug eruptions, and lichenoid drug eruptions.
Clin Dermatol. 2020 Nov-Dec;38(6):679-692. doi: 10.1016/j.clindermatol.2020.06.010. Epub 2020 Jun 26.
3
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
4
Six months into the pandemic. A review of skin manifestations in SARS-CoV-2 infection.
Dermatol Ther. 2021 Jan;34(1):e14641. doi: 10.1111/dth.14641. Epub 2020 Dec 14.
5
Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant - a cross-sectional study.
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e183-e185. doi: 10.1111/jdv.17051. Epub 2020 Dec 21.
6
Severe Herpes Zoster Following Varicella Vaccination in Immunocompetent Young Children.
J Child Neurol. 2019 Mar;34(4):184-188. doi: 10.1177/0883073818821498. Epub 2019 Jan 10.
7
Lichen planus and lichenoid drug eruption after vaccination.
Cutis. 2017 Dec;100(6):E6-E20.
8
Herpes Zoster in the Older Adult.
Infect Dis Clin North Am. 2017 Dec;31(4):811-826. doi: 10.1016/j.idc.2017.07.016.
Zotero 插件